DiaMedica Therapeutics Appoints David Wambeke as Chief Business Officer

Go back to DiaMedica Therapeutics Appoints David Wambeke as Chief Business Officer
(NASDAQ: DMAC) Delayed: 6.33 -0.14 (2.16%)
Previous Close $6.47    52 Week High
Open $6.57    52 Week Low
Day High $6.88    P/E N/A 
Day Low $6.33    EPS
Volume 57,102